251 related articles for article (PubMed ID: 1965166)
21. Lead mobilization during calcium disodium ethylenediaminetetraacetate chelation therapy in treatment of chronic lead poisoning.
Sánchez-Fructuoso AI; Cano M; Arroyo M; Fernández C; Prats D; Barrientos A
Am J Kidney Dis; 2002 Jul; 40(1):51-8. PubMed ID: 12087561
[TBL] [Abstract][Full Text] [Related]
22. Dose-response study of oral 2,3-dimercaptosuccinic acid in children with elevated blood lead concentrations.
Graziano JH; Lolacono NJ; Meyer P
J Pediatr; 1988 Oct; 113(4):751-7. PubMed ID: 2845043
[TBL] [Abstract][Full Text] [Related]
23. [Effects of chelation therapy with succimer in young rabbits of moderate lead poisoning].
Yu GY; Yan CH; Yu XG; Zuo Y; Zou XY; Xu J; Wu SH; Shen XM
Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jan; 43(1):8-13. PubMed ID: 19534872
[TBL] [Abstract][Full Text] [Related]
24. Intramuscular administration of iron during long-term chelation therapy with 2,3-dimercaptosuccinic acid in a man with severe lead poisoning.
Haust HL; Inwood M; Spence JD; Poon HC; Peter F
Clin Biochem; 1989 Jun; 22(3):189-96. PubMed ID: 2544323
[TBL] [Abstract][Full Text] [Related]
25. Succimer chelation does not produce lasting reductions of blood lead levels in a rodent model of retained lead fragments.
Twardy SM; Hanson SM; Jursa T; Gaitens JM; Kalinich JM; McDiarmid MA; Smith DR
Environ Toxicol Pharmacol; 2023 Nov; 104():104283. PubMed ID: 37775076
[TBL] [Abstract][Full Text] [Related]
26. Oral treatment of avian lead intoxication with meso-2,3-dimercaptosuccinic acid.
Hoogesteijn AL; Raphael BL; Calle P; Cook R; Kollias G
J Zoo Wildl Med; 2003 Mar; 34(1):82-7. PubMed ID: 12723805
[TBL] [Abstract][Full Text] [Related]
27. Lead poisoning and chelation in a mother-neonate pair.
Horowitz BZ; Mirkin DB
J Toxicol Clin Toxicol; 2001; 39(7):727-31. PubMed ID: 11778671
[TBL] [Abstract][Full Text] [Related]
28. Effect of chelate treatments on kidney, bone and brain lead levels of lead-intoxicated mice.
Jones MM; Basinger MA; Gale GR; Atkins LM; Smith AB; Stone A
Toxicology; 1994 Apr; 89(2):91-100. PubMed ID: 8197593
[TBL] [Abstract][Full Text] [Related]
29. Impacts of lead exposure and chelation therapy on bone metabolism during different developmental stages of rats.
Zhang Y; Zhou L; Li S; Liu J; Sun S; Ji X; Yan C; Xu J
Ecotoxicol Environ Saf; 2019 Nov; 183():109441. PubMed ID: 31404725
[TBL] [Abstract][Full Text] [Related]
30. Effect of chelation therapy on the neuropsychological and behavioral development of lead-exposed children after school entry.
Dietrich KN; Ware JH; Salganik M; Radcliffe J; Rogan WJ; Rhoads GG; Fay ME; Davoli CT; Denckla MB; Bornschein RL; Schwarz D; Dockery DW; Adubato S; Jones RL;
Pediatrics; 2004 Jul; 114(1):19-26. PubMed ID: 15231903
[TBL] [Abstract][Full Text] [Related]
31. The scientific basis for chelation: animal studies and lead chelation.
Smith D; Strupp BJ
J Med Toxicol; 2013 Dec; 9(4):326-38. PubMed ID: 24113857
[TBL] [Abstract][Full Text] [Related]
32. Chelation therapy in intoxications with mercury, lead and copper.
Cao Y; Skaug MA; Andersen O; Aaseth J
J Trace Elem Med Biol; 2015; 31():188-92. PubMed ID: 24894443
[TBL] [Abstract][Full Text] [Related]
33. Effects of calcium disodium versenate (CaNa2EDTA) chelation in moderate childhood lead poisoning.
Markowitz ME; Bijur PE; Ruff H; Rosen JF
Pediatrics; 1993 Aug; 92(2):265-71. PubMed ID: 8337028
[TBL] [Abstract][Full Text] [Related]
34. Chelation therapy to treat lead toxicity in children.
Wegmann K
Minn Med; 1992 Nov; 75(11):25-7. PubMed ID: 1331737
[TBL] [Abstract][Full Text] [Related]
35. Lead induced oxidative stress and its recovery following co-administration of melatonin or N-acetylcysteine during chelation with succimer in male rats.
Flora SJ; Pande M; Kannan GM; Mehta A
Cell Mol Biol (Noisy-le-grand); 2004; 50 Online Pub():OL543-51. PubMed ID: 15555419
[TBL] [Abstract][Full Text] [Related]
36. Mobilization of lead by calcium versenate and dimercaptosuccinate in the rat.
Tandon SK; Singh S; Prasad S; Mathur N
Clin Exp Pharmacol Physiol; 1998 Sep; 25(9):686-92. PubMed ID: 9750957
[TBL] [Abstract][Full Text] [Related]
37. Trends in the management of childhood lead poisonings.
Rosen JF; Markowitz ME
Neurotoxicology; 1993; 14(2-3):211-7. PubMed ID: 8247394
[TBL] [Abstract][Full Text] [Related]
38. Management of childhood lead poisoning: a survey.
Glotzer DE; Bauchner H
Pediatrics; 1992 Apr; 89(4 Pt 1):614-8. PubMed ID: 1313555
[TBL] [Abstract][Full Text] [Related]
39. The management of environmental lead exposure in the pediatric population: lessons from Clitty Creek, Thailand.
Tantanasrikul S; Chaivisuth B; Siriratanapreuk S; Padungtod C; Pleubreukan R; Boonnark T; Worahan S; Bhumiratanarak P; Chomchai C
J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S762-8. PubMed ID: 12403258
[TBL] [Abstract][Full Text] [Related]
40. The impact of succimer chelation on blood cadmium in children with background exposures: a randomized trial.
Cao Y; Chen A; Bottai M; Caldwell KL; Rogan WJ
J Pediatr; 2013 Aug; 163(2):598-600. PubMed ID: 23601497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
